New drug application
Byfavo Powder For Solution For Injection 20mg
5 June 2026
The summary report for this therapeutic product is available for download
Summary report for Veoza
Active ingredient | Product Registrant | Approval date | Summary report |
|---|---|---|---|
Remimazolam besylate | Hyphens Pharma Pte. Ltd. | 27 Aug 2025 | Byfavo Powder For Solution for Injection 20mg [PDF, 1.72 MB] |
